Annual FCF
-$8.40 M
+$20.54 M+70.98%
December 31, 2023
Summary
- As of February 27, 2025, IMNM annual free cash flow is -$8.40 million, with the most recent change of +$20.54 million (+70.98%) on December 31, 2023.
- During the last 3 years, IMNM annual FCF has risen by +$4.32 million (+33.97%).
- IMNM annual FCF is now -10.02% below its all-time high of -$7.63 million, reached on December 31, 2018.
Performance
IMNM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$40.07 M
+$12.39 M+23.62%
September 30, 2024
Summary
- As of February 27, 2025, IMNM quarterly free cash flow is -$40.07 million, with the most recent change of +$12.39 million (+23.62%) on September 30, 2024.
- Over the past year, IMNM quarterly FCF has stayed the same.
- IMNM quarterly FCF is now -266.49% below its all-time high of $24.07 million, reached on March 31, 2023.
Performance
IMNM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$138.68 M
-$31.42 M-29.29%
September 30, 2024
Summary
- As of February 27, 2025, IMNM TTM free cash flow is -$138.68 million, with the most recent change of -$31.42 million (-29.29%) on September 30, 2024.
- Over the past year, IMNM TTM FCF has stayed the same.
- IMNM TTM FCF is now -3814.84% below its all-time high of $3.73 million, reached on June 30, 2023.
Performance
IMNM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IMNM Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +71.0% | 0.0% | 0.0% |
3 y3 years | +34.0% | -493.2% | -379.2% |
5 y5 years | -10.0% | -493.2% | -379.2% |
IMNM Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +71.0% | -266.5% | +23.6% | -3814.8% | at low |
5 y | 5-year | at high | +71.0% | -266.5% | +23.6% | -3814.8% | at low |
alltime | all time | -10.0% | +71.0% | -266.5% | +23.6% | -3814.8% | at low |
Immunome Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$40.07 M(-23.6%) | -$138.68 M(+29.3%) |
Jun 2024 | - | -$52.46 M(+85.1%) | -$107.26 M(+76.4%) |
Mar 2024 | - | -$28.34 M(+59.1%) | -$60.81 M(+624.0%) |
Dec 2023 | -$8.40 M(-71.0%) | -$17.81 M(+105.9%) | -$8.40 M(-416.5%) |
Sep 2023 | - | -$8.65 M(+44.0%) | $2.65 M(-28.9%) |
Jun 2023 | - | -$6.01 M(-125.0%) | $3.73 M(+147.1%) |
Mar 2023 | - | $24.07 M(-456.3%) | $1.51 M(-105.2%) |
Dec 2022 | -$28.94 M | -$6.75 M(-10.8%) | -$28.94 M(-0.2%) |
Sep 2022 | - | -$7.57 M(-8.0%) | -$29.00 M(+13.3%) |
Jun 2022 | - | -$8.23 M(+29.0%) | -$25.60 M(+21.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$6.38 M(-6.4%) | -$21.12 M(+15.4%) |
Dec 2021 | -$18.30 M(+43.9%) | -$6.82 M(+63.5%) | -$18.30 M(+4.0%) |
Sep 2021 | - | -$4.17 M(+11.3%) | -$17.59 M(+9.4%) |
Jun 2021 | - | -$3.75 M(+5.1%) | -$16.07 M(+13.5%) |
Mar 2021 | - | -$3.57 M(-41.6%) | -$14.17 M(+11.4%) |
Dec 2020 | -$12.72 M(+29.4%) | -$6.11 M(+130.3%) | -$12.72 M(+92.4%) |
Sep 2020 | - | -$2.65 M(+44.1%) | -$6.61 M(+67.0%) |
Jun 2020 | - | -$1.84 M(-13.1%) | -$3.96 M(+86.9%) |
Mar 2020 | - | -$2.12 M | -$2.12 M |
Dec 2019 | -$9.83 M(+28.8%) | - | - |
Dec 2018 | -$7.63 M | - | - |
FAQ
- What is Immunome annual free cash flow?
- What is the all time high annual FCF for Immunome?
- What is Immunome annual FCF year-on-year change?
- What is Immunome quarterly free cash flow?
- What is the all time high quarterly FCF for Immunome?
- What is Immunome quarterly FCF year-on-year change?
- What is Immunome TTM free cash flow?
- What is the all time high TTM FCF for Immunome?
- What is Immunome TTM FCF year-on-year change?
What is Immunome annual free cash flow?
The current annual FCF of IMNM is -$8.40 M
What is the all time high annual FCF for Immunome?
Immunome all-time high annual free cash flow is -$7.63 M
What is Immunome annual FCF year-on-year change?
Over the past year, IMNM annual free cash flow has changed by +$20.54 M (+70.98%)
What is Immunome quarterly free cash flow?
The current quarterly FCF of IMNM is -$40.07 M
What is the all time high quarterly FCF for Immunome?
Immunome all-time high quarterly free cash flow is $24.07 M
What is Immunome quarterly FCF year-on-year change?
Over the past year, IMNM quarterly free cash flow has changed by $0.00 (0.00%)
What is Immunome TTM free cash flow?
The current TTM FCF of IMNM is -$138.68 M
What is the all time high TTM FCF for Immunome?
Immunome all-time high TTM free cash flow is $3.73 M
What is Immunome TTM FCF year-on-year change?
Over the past year, IMNM TTM free cash flow has changed by $0.00 (0.00%)